Roche: Q3 sales up 7% at constant exchange rates, momentum continues
FROM THE WIRE · FINANCE.YAHOO.COM
F. Hoffmann-La Roche Ltd Ad hoc announcement pursuant to Art. 53 LR Basel, 22 October 2026 Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishSales growth in pharma and diagnostics at a large Swiss group could move the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Group sales in the first nine months rose 6% at constant exchange rates.
- 02In Q3 sales grew 7% at CER and 8% in CHF.
- 03The Pharmaceuticals Division grew 7% at CER in the nine months.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets